APS
29th APS Annual Convention · 2017
Adverse Effects in a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy: Predictors and Risk Factors
Session: Poster Session VIII
Authors
- Kaia SargentPresenting Author
Brown University - Willoughby Britton
Brown University - Jared Lindahl
Brown University
Abstract
We investigated the role of baseline psychopathology as a risk factor for meditation-related adverse effects (AEs). AEs were assessed using the Meditation Experiences scale in a randomized controlled trial of Mindfulness-Based Cognitive Therapy. Participants with a baseline diagnosis of major depressive disorder or schizotypal personality disorder experienced significantly more AEs.
Other
